Skip to main content
. 2024 Mar 27;14:1351995. doi: 10.3389/fonc.2024.1351995

Table 1.

Patient demographics and disease characteristics.

Characteristics Number of patients
n = 279 (%)
Age (continuous)
Median (range) 65.5 (34.2-79.3)
Age (categorical)
<75 257 (92.1)
≥75 22 (7.9)
Sex
Male 187 (67.0)
Female 92 (33.0)
Histology
Adenocarcinoma 273 (97.9)
NOS carcinoma 6 (2.1)
Large cell lung cancer 0 (0.0)
Adenosquamous 0 (0.0)
Squamous 0 (0.0)
Unknown—N/D 0
EGFR status known
Yes 279 (100.0)
No 0 (0.0)
EGFR mutation
Negative 279 (100.0)
ALK status known
Yes 279 (100.0)
No 0 (0.0)
ALK status known
Negative 279 (100.0)
PDL1
<1% 123 (44.1)
1%–49% 156 (55.9)
≥50% 0
PS ECOG
0 107 (39.5)
1 148 (54.6)
2 16 (5.9)
Unknown 8
Smoking history
Ex-smoker 59 (41.8)
Smoker 49 (34.8)
Not smoker 33 (23.4)
Unknown 138
Presence of brain metastases
Yes 48 (17.6)
No 225 (82.4)
Unknown 6

Percentages reported in the table were calculated using the number of patients with available data (for each variable).